Valuation : CanSino Biologics Inc.

Market Cap 12.02B 14.03B 1.79B 1.54B 1.45B 1.32B 2.49B 170B 2.5B 17.16B 6.68B 86.37B 6.72B 6.57B 286B P/E 2026 *
48.7x
P/E 2027 * 19.4x
Enterprise Value 11.94B 13.93B 1.78B 1.53B 1.44B 1.31B 2.47B 169B 2.48B 17.04B 6.63B 85.76B 6.67B 6.52B 284B EV / Sales 2026 *
8.29x
EV / Sales 2027 * 6.71x
Free-Float
39.3%
Yield 2026 *
-
Yield 2027 * -
1 week+4.17%
1 month+26.72%
3 months+13.37%
6 months-16.85%
Current year-15.52%
1 week 28.82
Extreme 28.82
38.14
1 month 22.82
Extreme 22.82
40
Current year 19.22
Extreme 19.22
41.64
1 year 19.22
Extreme 19.22
56.55
3 years 14.8
Extreme 14.8
56.55
5 years 14.8
Extreme 14.8
310
10 years 14.8
Extreme 14.8
450
Manager TitleAgeSince
Corporate Officer/Principal 66 21/02/2024
Corporate Officer/Principal 64 13/01/2009
Chief Tech/Sci/R&D Officer 53 13/01/2009
Director TitleAgeSince
Chairman 62 13/01/2009
Director/Board Member 63 28/05/2021
Director/Board Member 63 22/06/2018
Date Insider Type Main position Quantity % Market Cap. Importance
26/08/25 Sell

Director

4,600 0.0069%
26/09/24 Other

Chief Executive Officer

20,000 0.0151%
09/09/24 Other

Founder

30,000 0.0226%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+4.17%-42.04%+28.26% 1.78B
+3.10%-1.17%+41.87%-0.94% 79.79B
+0.02%-0.06%-17.30%-35.80% 58.85B
+9.93%-2.87%+540.39%+37.06% 56.03B
+0.13%-4.10%-0.74%+34.87% 51.26B
+1.49%-2.50%+9.69%+163.06% 47.68B
-0.28%-2.14%+63.39%-19.14% 32.01B
+1.45%-3.63%+47.75%+93.24% 24.98B
-2.12%+1.50%-3.61%+189.46% 23.05B
+1.69%-2.60%+61.63%+116.78% 16.31B
Average +1.54%-0.13%+70.10%+60.69% 39.17B
Weighted average by Cap. +2.27%-1.44%+94.69%+44.66%

Financials

2026 *2027 *
Net sales 1.41B 1.64B 209M 180M 170M 155M 291M 19.85B 292M 2.01B 781M 10.1B 785M 768M 33.49B 1.81B 2.11B 270M 233M 219M 199M 375M 25.59B 377M 2.59B 1.01B 13.02B 1.01B 990M 43.16B
Net income 127M 148M 18.9M 16.3M 15.33M 13.97M 26.27M 1.79B 26.41M 181M 70.56M 912M 70.95M 69.41M 3.03B 80M 93.32M 11.9M 10.27M 9.66M 8.8M 16.55M 1.13B 16.63M 114M 44.44M 575M 44.69M 43.72M 1.91B
Net Debt -85.1M -99.27M -12.66M -10.92M -10.27M -9.36M -17.6M -1.2B -17.7M -121M -47.27M -611M -47.54M -46.51M -2.03B -581M -677M -86.38M -74.51M -70.09M -63.86M -120M -8.2B -121M -829M -323M -4.17B -324M -317M -13.83B
Logo CanSino Biologics Inc.
CanSino Biologics Inc is a China-based company primarily engaged in the research and development, production, and commercialization of human vaccine products. The Company’s products and product pipeline under research include multiple vaccine varieties such as meningitis, pneumonia, diphtheria, tetanus, and pertussis (DPT), coronavirus disease 2019 (COVID-19), Ebola virus disease, poliomyelitis, herpes zoster, tuberculosis and others. The Company is also engaged in the research and development of pharmaceutical production processes. The Company conducts its business in the domestic and overseas markets.
Employees
1,134
Date Price Change Volume
01/09/26 HK$29.50 0.00% 8,857,280
31/08/26 HK$29.50 -7.12% 7,923,678
28/08/26 HK$31.76 -9.77% 10,062,200
27/08/26 HK$35.20 -1.35% 26,548,260
26/08/26 HK$35.68 +25.99% 29,539,292
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
25.29CNY
Average target price
40.66CNY
Spread / Average Target
+60.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6185 Stock